These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 2032216

  • 1. Augmented binding of radiolabeled monoclonal antibodies to melanoma cells using specific antibody combinations.
    Mujoo K, Rosenblum MG, Murray JL.
    Cancer Res; 1991 Jun 01; 51(11):2768-72. PubMed ID: 2032216
    [Abstract] [Full Text] [Related]

  • 2. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
    Lin K, Nagy JA, Xu H, Shockley TR, Yarmush ML, Dvorak HF.
    Cancer Res; 1994 Apr 15; 54(8):2269-77. PubMed ID: 8174137
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of temperature on radiochemical purity and immunoreactivity of radiolabeled monoclonal antibody 1H10.
    Huang WS, Cherng SC, Jen TK, Yu MH, Yeh MY.
    J Nucl Med Technol; 2000 Sep 15; 28(3):182-5. PubMed ID: 11001503
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
    Sung C, Shockley TR, Morrison PF, Dvorak HF, Yarmush ML, Dedrick RL.
    Cancer Res; 1992 Jan 15; 52(2):377-84. PubMed ID: 1728409
    [Abstract] [Full Text] [Related]

  • 9. Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.
    Murray JL, Zukiwski AA, Mujoo K, Rosenblum MG.
    J Biol Response Mod; 1990 Dec 15; 9(6):556-63. PubMed ID: 2074442
    [Abstract] [Full Text] [Related]

  • 10. Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface antigenic determinants.
    Krizan Z, Murray JL, Hersh EM, Rosenblum MG, Glenn HJ, Gschwind CR, Carlo DJ.
    Cancer Res; 1985 Oct 15; 45(10):4904-9. PubMed ID: 2411391
    [Abstract] [Full Text] [Related]

  • 11. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T, Ishihara T, Campoli M, Ferrone S.
    Tissue Antigens; 2005 May 15; 65(5):419-28. PubMed ID: 15853896
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
    Sharkey RM, Gold DV, Aninipot R, Vagg R, Ballance C, Newman ES, Ostella F, Hansen HJ, Goldenberg DM.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):828s-834s. PubMed ID: 2297729
    [Abstract] [Full Text] [Related]

  • 14. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI, Altomonte M, Fonsatti E, Colizzi F, Coral S, Nicotra MR, Cattarossi I, Cattelan A, Natali PG, Maio M.
    Lab Invest; 1996 Jan 01; 74(1):33-42. PubMed ID: 8569195
    [Abstract] [Full Text] [Related]

  • 15. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
    Casalini P, Luison E, Ménard S, Colnaghi MI, Paganelli G, Canevari S.
    J Nucl Med; 1997 Sep 01; 38(9):1378-81. PubMed ID: 9293791
    [Abstract] [Full Text] [Related]

  • 16. Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibody.
    Lindmo T, Boven E, Mitchell JB, Morstyn G, Bunn PA.
    Cancer Res; 1985 Oct 01; 45(10):5080-7. PubMed ID: 4027987
    [Abstract] [Full Text] [Related]

  • 17. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
    Desai SA, Wang X, Noronha EJ, Kageshita T, Ferrone S.
    Cancer Res; 1998 Jun 01; 58(11):2417-25. PubMed ID: 9622083
    [Abstract] [Full Text] [Related]

  • 18. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
    Coney LR, Mezzanzanica D, Sanborn D, Casalini P, Colnaghi MI, Zurawski VR.
    Cancer Res; 1994 May 01; 54(9):2448-55. PubMed ID: 7512887
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells.
    Herlyn D, Powe J, Ross AH, Herlyn M, Koprowski H.
    J Immunol; 1985 Feb 01; 134(2):1300-4. PubMed ID: 3965572
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J, Andersson H, Bäck T, Hultborn R, Jensen H, Karlsson B, Lindegren S, Palm S, Warnhammar E, Jacobsson L.
    J Nucl Med; 2005 Nov 01; 46(11):1907-15. PubMed ID: 16269606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.